bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
3.540
-0.460 (-11.50%)
At close: Mar 30, 2026, 4:00 PM EDT
3.500
-0.040 (-1.13%)
Pre-market: Mar 31, 2026, 8:26 AM EDT

bioAffinity Technologies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
165141413-
Market Cap Growth
178.17%-62.54%2.63%2.98%--
Enterprise Value
10.62-0.3613.8712.112.250
Last Close Price
3.541.1827.3044.1048.00-
PE Ratio
--0.14-1.21-1.62-0.88-
PS Ratio
2.580.861.515.452792.02-
PB Ratio
2.190.735.452.841.21-
P/TBV Ratio
0.840.284.242.650.65-
P/FCF Ratio
--0.57-1.93-2.28-3.13-
P/OCF Ratio
--0.57-1.95-2.29-3.29-
EV/Sales Ratio
1.72-0.061.484.78468.06-
EV/EBITDA Ratio
-0.04-1.66-1.57-0.56-
EV/EBIT Ratio
-0.03-1.55-1.52-0.56-
EV/FCF Ratio
-0.04-1.89-2.00-0.52-
Debt / Equity Ratio
0.110.110.310.230.02-0.96
Debt / EBITDA Ratio
-0.11-0.11-0.18-0.20-0.06-5.16
Debt / FCF Ratio
-0.12-0.12-0.20-0.26-0.06-5.55
Net Debt / Equity Ratio
-0.73-0.730.15-0.26-1.01-0.63
Net Debt / EBITDA Ratio
0.530.53-0.050.162.79-4.54
Net Debt / FCF Ratio
0.560.56-0.050.212.60-4.88
Asset Turnover
0.710.711.270.250.000
Inventory Turnover
104.16104.16259.63144.930.17-
Quick Ratio
2.412.410.721.6210.030.10
Current Ratio
2.602.600.871.7710.500.11
Return on Equity (ROE)
-301.83%-301.83%-242.44%-99.84%2319.94%55.56%
Return on Assets (ROA)
-120.51%-120.65%-121.37%-77.95%-58.82%-275.96%
Return on Invested Capital (ROIC)
-416.70%-417.19%-268.21%-450.95%430.89%154.95%
Return on Capital Employed (ROCE)
-184.46%-184.46%-190.85%-93.71%1477.98%19.56%
Earnings Yield
-93.71%-733.90%-82.42%-61.90%-113.13%-
FCF Yield
-59.02%-176.88%-51.82%-43.89%-32.00%-
Buyback Yield / Dilution
-325.83%-325.83%-38.61%-94.43%--
Total Shareholder Return
-325.83%-325.83%-38.61%-94.43%--
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q